THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract

Phase 4

Conditions: Age Related Macular Degeneration
Cataract

Interventions: Dietary Supplement: Multivitamin
Dietary Supplement: Cocoa extract
Dietary Supplement: Cocoa extract placebo
Dietary Supplement: Multivitamin placebo

First Posted Date: 2017-07-02

Last Posted Date: 2021-09-17

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 21442

Registration Number: NCT03205202

Hospital-Level Care at Home for Acutely Ill Adults

Not Applicable

Completed

Conditions: Heart Failure
COPD
Asthma
Gout Flare
Atrial Fibrillation Rapid
Anticoagulants; Increased
Infection
Chronic Kidney Diseases
Hypertensive Urgency

Interventions: Other: Traditional inpatient hospitalization
Other: Home hospitalization

First Posted Date: 2017-06-29

Last Posted Date: 2018-08-29

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 91

Registration Number: NCT03203759

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Faulkner Hospital, Boston, Massachusetts, United States

Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea

Phase 2

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Device: Oral appliance
Drug: Oxygen
Other: Oral appliance plus oxygen
Other: No treatment

First Posted Date: 2017-06-16

Last Posted Date: 2025-05-04

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 41

Registration Number: NCT03189173

Locations: 🇦🇺
Sleep and Circadian Medicine Laboratory, BASE Facility, Monash University, Notting Hill, Victoria, Australia
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Measurement of Renal Functional Reserve

Not Applicable

Completed

Conditions: Kidney Diseases

Interventions: Dietary Supplement: Ingestion of protein

First Posted Date: 2017-06-16

Last Posted Date: 2022-08-10

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 47

Registration Number: NCT03190070

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Post-Acute Physician Home Visit Program

Not Applicable

Completed

Conditions: A Patient Discharged From an Acute-care Hospital Who Had an Acute Illness

Interventions: Other: Home visit

First Posted Date: 2017-06-07

Last Posted Date: 2019-08-13

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 51

Registration Number: NCT03178513

Locations: 🇺🇸
Brigham and Women's Faulkner Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography

Phase 1

Completed

Conditions: Pulmonary Embolism

Interventions: Drug: Ferumoxytol

First Posted Date: 2017-06-01

Last Posted Date: 2022-07-26

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 1

Registration Number: NCT03173066

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Angiogenic Imaging in Pulmonary Arterial Hypertension

Phase 1

Completed

Conditions: Pulmonary Arterial Hypertension
Exercise Associated Pulmonary Arterial Hypertension

Interventions: Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab

First Posted Date: 2017-05-25

Last Posted Date: 2021-05-06

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 5

Registration Number: NCT03166306

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults

Phase 4

Withdrawn

Conditions: Delirium in Old Age

Interventions: Drug: Placebo
Drug: Ramelteon

First Posted Date: 2017-05-24

Last Posted Date: 2020-01-22

Lead Sponsor: Brigham and Women's Hospital

Registration Number: NCT03165695

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV

Not Applicable

Completed

Conditions: HIV/AIDS
Tuberculosis

Interventions: Other: Same-Day Treatment
Other: Standard treatment

First Posted Date: 2017-05-16

Last Posted Date: 2022-09-09

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 500

Registration Number: NCT03154320

Locations: 🇭🇹
GHESKIO, Port-au-Prince, Haiti

Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis

Completed

Conditions: Multiple Sclerosis
Healthy

Interventions: Other: Blood sampling (controls)
Other: Blood sampling (MS)

First Posted Date: 2017-05-03

Last Posted Date: 2021-01-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 161

Registration Number: NCT03138525

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy